Berlin - Delayed Quote • EUR (FR14007KL.BE) Follow 96.03 -0.02 (-0.02%) As of 9:39 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for FR14007KL.BE 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Related News View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Q3 2024 Microsoft Corp Earnings Call Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments 2 Artificial Intelligence (AI) Chip Stocks to Watch That Aren't Nvidia Dividend Watch: Your Move, Amazon Dow Jones Futures Higher After Inflation Data; Tesla Slides On Probe Into Autopilot Recall Charter Communications reports higher-than-expected broadband subscriber losses Stocks Rise as Inflation Signals More of the Same: Markets Wrap AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates Despite Revenue Challenges AbbVie Beats First-Quarter Views As Skyrizi Looks To Take Humira's Title US STOCKS-Wall St set to open higher on tech boost, PCE data Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure Key Fed Inflation Rate Averts Worst Fears; S&P 500 Futures Rise
